Ep 35 | Top 10 Developments in 340B for 2023
For our last episode of 2023, Greg and Rob reviewed hot topics impacting 340B covered entities from the past year.
18 Dec 20231h 5min
Ep 34 | Maintaining 340B Compliance: The Importance of Self-Auditing
In this episode, Greg and Rob are joined by Spendmend colleague Cat Eriksen (16:11) to discuss the importance of self-auditing as part of a 340B covered entity’s overall compliance strategy. They’ll t...
4 Dec 202344min
Ep 33 | Thoughts on the Genesis v. Becerra Court Ruling
In this episode, Rob and Greg share thoughts from the recent federal court ruling on the Genesis v Becerra case, which focuses on patient definition. Additionally, they catch up on manufacturer restr...
20 Nov 202338min
Ep 32 | Getting to Know the HRSA DRL: Part 1 – Policies & Procedures
This episode is the first part of a series of recordings we are putting together to review the HRSA data request list (DRL). Rob and Greg discuss DRL item #1 – 340B Policies and Procedures. They’ll r...
6 Nov 202358min
Bonus Ep 2 | HRSA Notice Addressing 340B Registration Requirements
In this bonus episode, Rob and Greg review the HRSA notice published on October 27 that addresses the immediate use of 340B drugs in unregistered locations and some hospital considerations in response...
27 Okt 202324min
Ep 31 | Answering 340B FAQs - Rob vs. ChatGPT
In this episode, Rob is pitted against ChatGPT to answer 340B-related FAQs, including topics like child site registration, GPO prohibition, and HRSA audit findings (17:29). In the intro, Greg and Rob ...
23 Okt 20231h 2min
Ep 30 | Turnkey Pharmacy Solutions, Whiteboards & 340B Stuff
Rich Bucher, one of the co-founders of Turnkey Pharmacy Solutions, makes a long-awaited appearance on the podcast with Greg and Rob. Rich and Rob share anecdotes from their early days getting involve...
9 Okt 20231h 7min
Ep 29 | The Intersection Between the Inflation Reduction Act (IRA) & 340B – Conversation with Jeff Davis
In this episode, Greg and Rob are joined by healthcare attorney Jeff Davis, to discuss how the Medicare drug pricing provisions in the IRA will impact 340B providers. They’ll go over CMS billing modi...
25 Sep 20231h 9min
